Zobrazeno 1 - 10
of 479
pro vyhledávání: '"G. Fillet"'
Autor:
Pawluski, J.L. Paravatou, R. Even, A. Cobraiville, G. Fillet, M. Kokras, N. Dalla, C. Charlier, T.D.
One of the most frequently prescribed selective serotonin reuptake inhibitor medications (SSRIs) for peripartum mood and anxiety disorders is sertraline (Zoloft®). Sertraline can help alleviate mood and anxiety symptoms in many women but it is not k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::8b4f12565af835488e9a908d9db73780
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2997580
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2997580
Publikováno v:
Transplantation. :1692-1696
It is now well established that after conventional allogeneic hematopoietic stem-cell transplantation (HSCT), erythropoietic recovery is impaired because erythropoietin (Epo) production remains inadequate for prolonged periods of time. However, eryth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba240707a8445211a89c61d720ca9a97
https://doi.org/10.1097/00007890-200212270-00008
https://doi.org/10.1097/00007890-200212270-00008
Autor:
J, Collignon, C, Gennigens, A, Rorive, P, Coucke, E, Lifrange, S, Maweja, G, Fillet, G, Jerusalem
Publikováno v:
Revue medicale de Liege. 64(5-6)
About 9,500 new breast cancers are diagnosed in Belgium every year. Improvement of our knowledge of altered molecular events leading to the proliferation of tumor cells has resulted in the development of targeted therapies in subgroups of cancers. On
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fbf22ac2ec22d590b67b4d3f8442fe15
https://pubmed.ncbi.nlm.nih.gov/19642459
https://pubmed.ncbi.nlm.nih.gov/19642459
Publikováno v:
Revue medicale de Liege. 63(2)
This article describes the treatment of acute myeloid leukemia in older patients with good performance status, and then discusses briefly some future therapeutic perspectives.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::268dd1a1ddee585c334c2977704439ed
https://pubmed.ncbi.nlm.nih.gov/18372541
https://pubmed.ncbi.nlm.nih.gov/18372541
Publikováno v:
Revue medicale de Liege. 62(5-6)
This article focuses on recent advances in four important areas of hematology: aggressive lymphomas, allogeneic hematopoietic stem cell transplantation, multiple myeloma, and molecular therapy of cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c8bac2778b98ca36c90992f2382ef94f
https://pubmed.ncbi.nlm.nih.gov/17725211
https://pubmed.ncbi.nlm.nih.gov/17725211
Publikováno v:
JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR). 90(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0bd1207a30db41718e03e83d4fd522a7
https://pubmed.ncbi.nlm.nih.gov/17696095
https://pubmed.ncbi.nlm.nih.gov/17696095
Publikováno v:
Revue medicale de Liege. 60(9)
Patients with factitious disorders need to be ill and to defy physicians. These syndromes are difficult to diagnose because of the permanent disorder appearing inside the therapeutic relation. The case of a young woman who presents with a factitious
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1391bd9bbf409b71bb3b2f72eab51279
https://pubmed.ncbi.nlm.nih.gov/16267891
https://pubmed.ncbi.nlm.nih.gov/16267891
Publikováno v:
Revue medicale suisse. 1(30)
Allogeneic hematopoietic stem cell transplantation (HSCT) is used for the treatment of selected haematological malignancies. Its curative potential is based on two different mechanisms, i.e. the conditioning regimen and the graft-versus-host immunolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc96300797e0f448f98ed5feb54ce8f4
https://pubmed.ncbi.nlm.nih.gov/16200942
https://pubmed.ncbi.nlm.nih.gov/16200942
Publikováno v:
Revue medicale de Liege. 58(1)
This review article describes the identification of the tyrosine kinase BCR/ABL as the hallmark of chronic myeloid leukemias (CML) as well as the development of a specific inhibitor of this tyrosine kinase, the STI571 (Glivec, imatinib mesylate). The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::612e9e35563633aed73292efe56b08ad
https://pubmed.ncbi.nlm.nih.gov/12647591
https://pubmed.ncbi.nlm.nih.gov/12647591
Autor:
V, Warland, G, Jérusalem, R, Hustinx, Y, Beguin, R M, Silvestre, M F, Fassotte, J, Foidart-Willems, G, Fillet
Publikováno v:
Revue medicale de Liege. 57(12)
Incomplete regression of a lymphomatous mass after chemotherapy and/or radiotherapy constitutes a major problem in the treatment of lymphoma. In patients with persisting tumor, it could be reasonable to use salvage therapy and possibly hematopoietic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::34a5508396cb79bc1663004efd6b5bcb
https://pubmed.ncbi.nlm.nih.gov/12632835
https://pubmed.ncbi.nlm.nih.gov/12632835